≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Follicular lymphoma

Endpoint Browser PheWeb

CD2_FOLLICULAR_LYMPHOMA_EXALLC

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

None

-

2. Check conditions

None

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — C82
  • Hospital discharge: ICD-9 — 2000A
  • Cause of death: ICD-10 — C82
  • Cause of death: ICD-9 — 2000A

2 out of 7 registries used, show all original rules.

-

4. Check minimum number of events

None

-

5. Include endpoints

None

-

6. Filter based on genotype QC (FinnGen only)

None

-

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF12
Parent code in ICD-10
C81-C96
Name in latin
Lymphoma non-Hodgkin nodulare (folliculare)

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 1488 758 730
Unadjusted period prevalence (%) 0.29 0.26 0.32
Median age at first event (years) 64.01 63.06 65.00

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1340
Matched controls
13399
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
1730.0
323.0
375
*
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
57.3
323.0
395
97
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
323.0
745
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
283.6
323.0
867
86
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
+∞
323.0
354
*
XW000
NOMESCO Finland
Bone marrow biopsy
45.8
323.0
489
166
JN4BD
NOMESCO Finland
Extensive body CT
30.3
323.0
580
329
C82.01
ICD-10 Finland
Follicular nodular lymphoma, grade I
+∞
323.0
339
*
L03AA02
ATC
filgrastim; parenteral
574.1
323.0
312
7
A03FA01
ATC
metoclopramide; systemic, rectal
15.4
323.0
665
803
C82.2
ICD-10 Finland
Follicular lymphoma grade III, unspecified
+∞
316.5
291
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
1773.4
300.6
281
*
C82.00
ICD-10 Finland
Follicular nodular non-Hodgkin's lymphoma, ungraded
+∞
299.5
276
*
A04AA02
ATC
granisetron; systemic, transdermal
1086.4
278.4
263
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
270.2
250
*
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
172.6
268.3
275
20
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
262.3
243
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
2748.2
256.6
240
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
660.7
231.0
222
*
PJA10
NOMESCO Finland
Exploration of lymph nodes
131.3
225.8
238
22
M04AA01
ATC
allopurinol; systemic
8.7
223.4
573
1060
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
81.3
216.0
241
36
JN4AD
NOMESCO Finland
Body CT examination
21.0
205.7
316
194
H02AB02
ATC
dexamethasone; systemic
44.7
193.8
240
65
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
190.2
178
*
A04AA01
ATC
ondansetron; systemic, rectal
29.9
187.3
256
105
9691/3-C77.9
ICD-O-3
Follicular lymphoma, grade 2 of lymph node, NOS
+∞
172.7
162
*
WF002
NOMESCO Finland
Radical radiotherapy
377.1
166.0
164
5
JN6AD
NOMESCO Finland
CT of torso and neck
96.4
160.8
176
21
ZX120
NOMESCO Finland
Intravenous
8.8
138.6
324
466
WF049
NOMESCO Finland
Radiotherapy of metastasis
722.8
135.1
131
*
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
476.0
132.5
130
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
205.3
127.0
130
7
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
4.4
123.7
604
2115
1XC02
NOMESCO Finland
NA
89.0
122.9
136
17
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
115.3
109
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
114.2
108
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
21.5
113.2
170
90
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
9.4
112.4
248
315
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
111.0
105
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
105.6
100
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
10.6
103.4
212
234
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
74.5
102.4
116
17
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
67.1
96.5
111
18
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
+∞
94.9
90
*
WW500
NOMESCO Finland
Blood transfusion
16.5
91.7
151
102
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
479.1
91.4
90
*
XX3DW
NOMESCO Finland
Time consuming IT work
8.3
90.7
215
302
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.8
88.3
335
862
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
86.4
82
*
ZX112
NOMESCO Finland
Subcutaneous
35.5
85.5
111
34
D70.82
ICD-10 Finland
Drug-induced neutropenia
52.4
85.2
102
21
WF003
NOMESCO Finland
Adjuvant radiotherapy
287.8
80.5
81
*
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
283.9
79.4
80
*
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
29.4
78.0
106
39
R50.9
ICD-10 Finland
Fever, unspecified
4.6
77.7
309
823
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
71.4
76.4
87
13
9680/3-C77.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph node, NOS
+∞
74.7
71
*
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
+∞
74.7
71
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
758.3
73.9
72
*
9691/3-C77.8
ICD-O-3
Follicular lymphoma, grade 2 of lymph nodes of multiple regions
+∞
73.6
70
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
118.2
72.7
78
7
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
9.5
72.4
155
181
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.6
67.6
260
661
9690/3-C77.9
ICD-O-3
Follicular lymphoma, NOS, of lymph node, NOS
+∞
66.2
63
*
130
Kela drug reimbursment
Malignant tumour
+∞
64.1
61
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
64.1
61
*
PJA12
NOMESCO Finland
Sentinel node biopsy
227.4
63.7
65
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
8.4
63.2
146
193
115
Kela drug reimbursment
Breast cancer
+∞
63.0
60
*
9698/3-C77.9
ICD-O-3
Follicular lymphoma, grade 3 of lymph node, NOS
+∞
63.0
60
*
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
170.6
62.5
65
*
H02AB06
ATC
prednisolone; systemic
2.6
62.5
782
4642
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
+∞
61.9
59
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
42.3
61.1
76
19
N02AA05
ATC
oxycodone; systemic
4.0
60.8
276
815
C82.7
ICD-10 Finland
Other types of follicular lymphoma
+∞
59.8
57
*
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
78.4
59.6
67
9
JN4CD
NOMESCO Finland
Very extensive body CT
12.5
59.2
109
94
ZX070
NOMESCO Finland
Intensity modified radiotherapy
581.7
57.1
56
*
Z51.5
ICD-10 Finland
Palliative care
12.4
55.9
103
89
9695/3-C77.9
ICD-O-3
Follicular lymphoma, grade 1 of lymph node, NOS
+∞
55.6
53
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
55.6
53
*
L01AA02
ATC
chlorambucil; oral
559.9
55.0
54
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
549.1
53.9
53
*
C83.00
ICD-10 Finland
Lymphocytic lymphoma
+∞
53.5
51
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
145.9
53.2
56
*
C83.1
ICD-10 Finland
Mantle cell lymphoma
+∞
52.4
50
*
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
+∞
51.4
49
*
9691/3-C42.1
ICD-O-3
Follicular lymphoma, grade 2 of bone marrow
+∞
50.3
48
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
180.1
50.2
52
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.4
49.5
706
4276
H02AB07
ATC
prednisone; oral
3.2
48.4
299
1109
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
+∞
47.2
45
*
WZC30
NOMESCO Finland
Teaching
3.7
44.3
215
659
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
42.9
41
*
B72
ICPC
Hodgkin Lymphoma
+∞
42.9
41
*
J05AB11
ATC
valaciclovir; oral
3.1
41.0
252
921
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
40.8
39
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
9.5
39.9
84
94
116
Kela drug reimbursment
Prostate cancer
+∞
39.8
38
*
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
8.9
39.5
86
102
J01MA12
ATC
levofloxacin; systemic
2.7
39.5
325
1429
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
59.4
39.5
46
8
TPX10
NOMESCO Finland
Implantation of vascular injection port
10.8
39.4
77
75
212
Kela drug reimbursment
Gout
9.0
39.2
85
100
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
75.9
39.1
44
6
WW300
NOMESCO Finland
Transfer of autologic stem cells
205.9
39.0
40
*
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
+∞
38.7
37
*
9698/3-C77.8
ICD-O-3
Follicular lymphoma, grade 3 of lymph nodes of multiple regions
+∞
38.7
37
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
38.7
37
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
38.7
37
*
2000A
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Reticulosarcoma[LYMPHOMA MALIGNUM FOLLICULARE]
+∞
38.7
37
*
A02BC02
ATC
pantoprazole; systemic
2.2
38.0
922
6753
WX408
NOMESCO Finland
General anesthesy, balanced
2.4
37.7
395
1977
2008X
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Other named variants
+∞
37.7
36
*
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
63.4
37.3
43
7
HAC20
NOMESCO Finland
Total mastectomy
133.7
36.9
39
*
JN4ED
NOMESCO Finland
Body CT examination with specail preparation
+∞
36.6
35
*
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
25.2
36.4
51
21
C82.0
ICD-10 Finland
Follicular lymphoma grade I
+∞
35.6
34
*
TPJ00
NOMESCO Finland
Biopsy of superficial lymph node
356.1
35.1
35
*
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
+∞
34.5
33
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
34.5
33
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
34.5
33
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
8.5
34.1
76
94
C82
ICD-10 Finland
Follicular lymphoma
+∞
33.5
32
*
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
334.9
33.0
33
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
174.2
32.8
34
*
HA1AA
NOMESCO Finland
X-ray mammography
6.5
32.7
88
144
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
15.2
32.5
54
37
1AA09
NOMESCO Finland
NA
+∞
32.4
31
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
31.4
30
*
B01AB05
ATC
enoxaparin; parenteral
2.1
31.3
442
2505
TPH04
NOMESCO Finland
Cathetrisation of vein
2.4
31.2
331
1640
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
319.9
31.0
31
*
D70.89
ICD-10 Finland
Neutropenic splenomegaly
16.2
30.9
50
32
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
31.7
30.5
40
13
A04AA55
ATC
palonosetron, combinations; systemic
+∞
30.3
29
*
9591/3-C77.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph node, NOS
+∞
30.3
29
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
309.0
29.9
30
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
309.0
29.9
30
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.4
29.4
153
489
9591/3-C77.0
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of head, face and neck
+∞
29.3
28
*
C83.89
ICD-10 Finland
Other types of diffuse non-Hodgkin's lymphoma
+∞
28.2
27
*
YNB10
NOMESCO Finland
Collection of stem cells for transplant
287.2
27.8
28
*
A04AD12
ATC
aprepitant; systemic
287.2
27.8
28
*
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
8.7
27.5
60
72
C50.99
ICD-10 Finland
Breast, unspecified
+∞
27.2
26
*
9591/3-C77.4
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of inguinal region or leg
+∞
27.2
26
*
A07AA02
ATC
nystatin; oral
3.5
26.5
130
396
HAB40
NOMESCO Finland
Wedge excision of mammary gland
20.0
26.2
39
20
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
26.1
25
*
C81.2
ICD-10 Finland
Mixed cellularity classical Hodgkin lymphoma
+∞
26.1
25
*
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
+∞
26.1
25
*
9695/3-C77.8
ICD-O-3
Follicular lymphoma, grade 1 of lymph nodes of multiple regions
+∞
26.1
25
*
JAL01
NOMESCO Finland
Laparoscopic biopsy of peritoneum
74.2
25.9
29
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
265.4
25.8
26
*
A79
ICPC
Malignancy NOS
95.3
25.7
28
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.2
25.6
102
260
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.0
25.4
106
282
JAH01
NOMESCO Finland
Laparoscopy
5.2
25.2
80
161
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
25.1
24
*
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
59.2
25.1
29
5
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
71.3
24.9
28
*
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.7
24.7
86
192
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.2
23.8
133
445
L02BG04
ATC
letrozole; oral
18.5
23.6
36
20
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
55.0
23.1
27
5
ZX108
NOMESCO Finland
Inhalation
20.5
23.1
34
17
9690/3-C77.8
ICD-O-3
Follicular lymphoma, NOS, of lymph nodes of multiple regions
+∞
23.0
22
*
9591/3-C77.2
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of intra-abdominal lymph nodes
+∞
23.0
22
*
FM1FN
NOMESCO Finland
Heart function isotope examination
+∞
23.0
22
*
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
+∞
23.0
22
*
C96.9
ICD-10 Finland
Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified
+∞
23.0
22
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.0
22.9
363
2105
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
9.2
22.9
48
54
Z51.0
ICD-10 Finland
Radiotherapy session
233.7
22.7
23
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
3.9
22.6
96
259
J05AB01
ATC
aciclovir; systemic
2.1
22.4
301
1631
B01AB10
ATC
tinzaparin; parenteral
3.8
22.4
97
267
WX402
NOMESCO Finland
General anaesthesia
2.4
22.3
209
959
XX9CD
NOMESCO Finland
Very extensive complementary CT
+∞
21.9
21
*
C83.2
ICD-10 Finland
Mixed small and large cell (diffuse) non-Hodgkin's lymphoma
+∞
21.9
21
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
21.9
21
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
21.9
21
*
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
+∞
21.9
21
*
L02BA01
ATC
tamoxifen; oral
63.6
21.9
25
*
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
7.1
21.9
54
79
ZXE00
NOMESCO Finland
One hour or less
1.8
21.9
530
3561
WW409
NOMESCO Finland
Other aferesis
223.4
21.7
22
*
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
31.7
21.5
28
9
L02AE02
ATC
leuprorelin; implant, parenteral
31.7
21.5
28
9
N02BE01
ATC
paracetamol; systemic, rectal
2.0
21.1
1139
9856
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
5.5
21.0
63
119
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.7
20.9
628
4496
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
20.9
20
*
9680/3-C77.8
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions
+∞
20.9
20
*
JAH20
NOMESCO Finland
Staging laparotomy
213.1
20.6
21
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
4.0
20.6
85
224
JAH00
NOMESCO Finland
Laparotomy
6.3
20.3
54
88
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
9.8
19.9
40
42
A41.9
ICD-10 Finland
Sepsis, unspecified
3.9
19.9
84
226
C83.01
ICD-10 Finland
Lymphoplasmacytic lymphoma
+∞
19.8
19
*
C81.0
ICD-10 Finland
Nodular lymphocyte predominant Hodgkin lymphoma
+∞
19.8
19
*
9690/3-C77.4
ICD-O-3
Follicular lymphoma, NOS, of lymph nodes of inguinal region or leg
+∞
19.8
19
*
9691/3-C77.0
ICD-O-3
Follicular lymphoma, grade 2 of lymph nodes of head, face and neck
+∞
19.8
19
*
L01BC06
ATC
capecitabine; oral
+∞
19.8
19
*
L02BB03
ATC
bicalutamide; oral
+∞
19.8
19
*
WX110
NOMESCO Finland
Local anesthesy
1.7
19.8
840
6620
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.6
19.8
156
650
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.5
19.6
171
754
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
40.7
19.5
24
6
TGC00
NOMESCO Finland
Bronchial lavation
4.8
19.4
65
140
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
6.1
19.3
53
90
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.3
18.9
100
323
2000B
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Reticulosarcoma[LYMPHOMA MALIGNUM DIFFUSUM]
+∞
18.8
18
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
101.4
18.6
20
*
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
192.5
18.6
19
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
27.1
17.8
24
9
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.4
17.8
157
695
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
17.7
17
*
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
50.7
17.0
20
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
16.7
16
*
9690/3-C42.1
ICD-O-3
Follicular lymphoma, NOS, of bone marrow
+∞
16.7
16
*
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
3.6
16.6
76
220
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
16.5
16.6
26
16
JAH21
NOMESCO Finland
Staging laparoscopy
172.0
16.5
17
*
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
172.0
16.5
17
*
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
7.9
16.4
37
48
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
14.5
16.3
27
19
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
8.2
16.3
36
45
TPX15
NOMESCO Finland
Removal of vascular injection port
30.4
16.1
21
7
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
30.4
16.1
21
7
ZXE10
NOMESCO Finland
More than one and less than three hours
1.7
16.1
458
3158
L04.0
ICD-10 Finland
Acute lymphadenitis of face, head and neck
9.1
16.0
33
37
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.8
15.7
334
2103
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
6.2
15.7
42
70
C85.7
ICD-10 Finland
Other specified types of non-Hodgkin lymphoma
+∞
15.6
15
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
15.6
15
*
9690/3-C77.0
ICD-O-3
Follicular lymphoma, NOS, of lymph nodes of head, face and neck
+∞
15.6
15
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
15.6
15
*
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
2.9
15.6
99
362
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
22.3
15.6
22
10
J01MA14
ATC
moxifloxacin; systemic
2.4
15.2
135
597
AA1BD
NOMESCO Finland
Extensive CT of head and brain
5.1
15.1
47
94
I88.9
ICD-10 Finland
Nonspecific lymphadenitis, unspecified
12.6
14.9
26
21
YNB00
NOMESCO Finland
Excision of bone marrow for transplantation
57.3
14.8
17
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
14.6
14
*
L01BB05
ATC
fludarabine; systemic
+∞
14.6
14
*
L01CB01
ATC
etoposide; systemic
+∞
14.6
14
*
C90.0
ICD-10 Finland
Multiple myeloma
+∞
14.6
14
*
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
81.0
14.6
16
*
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
151.5
14.5
15
*
A06AH03
ATC
naloxegol; oral
27.5
14.3
19
7
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
13.5
14.2
24
18
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
6.7
14.1
35
53
B02
ICPC
Lymph gland(s) enlarged/painful
9.5
14.0
28
30
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
13.6
424
2966
UJF32
NOMESCO Finland
Coloscopy
1.7
13.6
333
2179
2009X
ICD-9 Finland
Lymphosarcoma and reticulosarcoma[LYMPHOMA MALIGNUM (NON-HODGKIN) NUD]
+∞
13.6
13
*
9680/3-C42.1
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of bone marrow
+∞
13.6
13
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
13.6
13
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
13.6
13
*
C83.0
ICD-10 Finland
Small cell B-cell lymphoma
+∞
13.6
13
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.7
13.4
376
2552
Y77
ICPC
Malignant neoplasm prostate
40.5
13.2
16
*
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
40.5
13.2
16
*
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
4.5
13.0
46
106
D11.0
ICD-10 Finland
Benign neoplasm: Parotid gland
4.7
13.0
44
97
L57.0
ICD-10 Finland
Actinic keratosis
2.3
13.0
119
535
SPAT1153
SPAT
Removal of sutures
1.6
13.0
419
2951
120
Kela drug reimbursment
Hypogammaglobulinaemia
50.5
12.9
15
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.8
12.8
223
1308
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
32.3
12.6
16
5
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
12.5
12
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
12.5
12
*
C81.7
ICD-10 Finland
Other classical Hodgkin lymphoma
+∞
12.5
12
*
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
+∞
12.5
12
*
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
12.5
12
*
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
+∞
12.5
12
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
12.5
12
*
Z85.7
ICD-10 Finland
Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues
+∞
12.5
12
*
PJ4AT
NOMESCO Finland
Labeling lymphnode with ultrasound guidance
+∞
12.5
12
*
C50
ICD-10 Finland
Malignant neoplasm of breast
131.1
12.5
13
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
131.1
12.5
13
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.3
12.4
113
509
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
37.9
12.2
15
*
KCD02
NOMESCO Finland
Transurethral resection of bladder
12.5
12.1
21
17
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
5.7
12.1
34
61
B02.9
ICD-10 Finland
Zoster without complication
2.5
12.1
94
390
WW200
NOMESCO Finland
Immunization
4.0
11.9
47
121
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
47.1
11.9
14
*
TDM10
NOMESCO Finland
Puncture of maxillary antrum
3.2
11.7
62
203
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
19.1
11.6
17
9
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
19.1
11.6
17
9
J01DB01
ATC
cefalexin; oral
1.6
11.5
1014
8905
9695/3-C77.0
ICD-O-3
Follicular lymphoma, grade 1 of lymph nodes of head, face and neck
+∞
11.5
11
*
L02BG06
ATC
exemestane; oral
+∞
11.5
11
*
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
11.5
11
*
372
Kela drug reimbursment
Idelalisib
+∞
11.5
11
*
9698/3-C77.0
ICD-O-3
Follicular lymphoma, grade 3 of lymph nodes of head, face and neck
+∞
11.5
11
*
9695/3-C77.4
ICD-O-3
Follicular lymphoma, grade 1 of lymph nodes of inguinal region or leg
+∞
11.5
11
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
11.5
11
*
PJ2HT
NOMESCO Finland
Biopsy of deep lymphnode with ultrasound guidance
+∞
11.5
11
*
PJD43
NOMESCO Finland
Excision of aortic lymph nodes
+∞
11.5
11
*
9690/3-C77.2
ICD-O-3
Follicular lymphoma, NOS, of intra-abdominal lymph nodes
+∞
11.5
11
*
Z08.8
ICD-10 Finland
Follow-up examination after other treatment for malignant neoplasm
+∞
11.5
11
*
C83.32
ICD-10 Finland
Centroblastic diffuse non-Hodgkin's lymphoma
+∞
11.5
11
*
OAA41
NOMESCO Finland
Health check based on individual needs
+∞
11.5
11
*
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
121.0
11.4
12
*
XX3AT
NOMESCO Finland
Other labeling with ultrasound guidance
121.0
11.4
12
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
121.0
11.4
12
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
121.0
11.4
12
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
3.6
11.4
51
147
D64.9
ICD-10 Finland
Anaemia, unspecified
2.0
11.3
141
727
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
35.3
11.3
14
*
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
4.8
11.2
36
76
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
17.2
11.2
17
10
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
4.6
11.2
38
85
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.7
11.1
47
129
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
11.0
285
1880
ZZR00
NOMESCO Finland
Flap of skin
10.7
10.8
20
19
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.6
10.8
321
2194
D48.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other specified sites
9.7
10.8
21
22
QX4AT
NOMESCO Finland
Ultrsound guided needle biopsy of skin
18.0
10.7
16
9
GEA00
NOMESCO Finland
Mediastinoscopy
21.6
10.7
15
7
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
60.5
10.6
12
*
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.5
10.6
417
3049
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
6.2
10.5
27
44
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
5.5
10.4
30
56
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
110.8
10.4
11
*
WW402
NOMESCO Finland
Leucoferesis
+∞
10.4
10
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
10.4
10
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
10.4
10
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
10.4
10
*
9695/3-C42.1
ICD-O-3
Follicular lymphoma, grade 1 of bone marrow
+∞
10.4
10
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
10.4
10
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
10.4
10
*
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
+∞
10.4
10
*
9691/3-C77.4
ICD-O-3
Follicular lymphoma, grade 2 of lymph nodes of inguinal region or leg
+∞
10.4
10
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
10.4
10
*
N03AX16
ATC
pregabalin; oral
1.6
10.3
293
1976
ZXF99
NOMESCO Finland
Other r3eason to interrupt procedure
18.9
10.3
15
8
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
23.5
10.2
14
6
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
6.3
10.2
26
42
JFB00
NOMESCO Finland
Partial resection of small intestine
6.3
10.2
26
42
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
13.2
10.2
17
13
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
5.8
10.0
27
47
ELB40
NOMESCO Finland
Partial parotidectomy
5.6
10.0
28
51
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
5.6
10.0
28
51
EMA10
NOMESCO Finland
Biopsy of tonsil
40.4
10.0
12
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.9
10.0
149
826
JN3AD
NOMESCO Finland
Abdominal CT examination
2.3
9.9
94
433
ZXD10
NOMESCO Finland
Scheduled procedure
1.5
9.8
464
3519
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
55.4
9.7
11
*
L03AA04
ATC
NA
55.4
9.7
11
*
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
6.0
9.5
25
42
R06AE07
ATC
cetirizine; oral
1.5
9.5
494
3816
128
Kela drug reimbursment
Cancers of female genital organs
100.7
9.4
10
*
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
100.7
9.4
10
*
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
30.2
9.4
12
*
TNE20
NOMESCO Finland
Bone marrow aspiration, pelvis
30.2
9.4
12
*
ZXA05
NOMESCO Finland
Left side
1.6
9.4
319
2245
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
9.4
9
*
9698/3-C42.1
ICD-O-3
Follicular lymphoma, grade 3 of bone marrow
+∞
9.4
9
*
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
+∞
9.4
9
*
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
+∞
9.4
9
*
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
+∞
9.4
9
*
1744A
ICD-9 Finland
Malignant neoplasm of female breast, Upper-outer quadrant
+∞
9.4
9
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
9.4
9
*
C44.81
ICD-10 Finland
Overall basocellular carcinoma of the skin
+∞
9.4
9
*
C80.99
ICD-10 Finland
Malignant tumor without specified localization or histology
+∞
9.4
9
*
9591/3-C77.8
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of multiple regions
+∞
9.4
9
*
9691/3-C07.9
ICD-O-3
Follicular lymphoma, grade 2 of parotid gland
+∞
9.4
9
*
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
+∞
9.4
9
*
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
+∞
9.4
9
*
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
9.4
9
*
C83
ICD-10 Finland
Non-follicular lymphoma
+∞
9.4
9
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
9.4
9
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
9.4
9
*
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
+∞
9.4
9
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
9.4
9
*
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
9.4
9
*
V03AF03
ATC
calcium folinate; systemic
+∞
9.4
9
*
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
9.4
9
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.5
9.4
378
2767
JAL00
NOMESCO Finland
Biopsy of peritoneum
21.9
9.4
13
6
J01MA02
ATC
ciprofloxacin; systemic
1.5
9.1
470
3614
TQW99
NOMESCO Finland
Other minor procedure on skin
2.9
9.1
54
193
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
3.0
9.1
52
180
WF099
NOMESCO Finland
Other radiotherapy
15.7
9.0
14
9
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
9.1
9.0
18
20
D69.5
ICD-10 Finland
Secondary thrombocytopenia
18.7
8.9
13
7
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
3.4
8.9
41
122
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
24.2
8.9
12
5
J35.1
ICD-10 Finland
Hypertrophy of tonsils
8.0
8.9
19
24
D37.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Small intestine
10.8
8.8
16
15
D37.00
ICD-10 Finland
Aryepiglottic fold marginal zone
10.8
8.8
16
15
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.6
8.7
236
1568
A02BC01
ATC
omeprazole; systemic
1.5
8.6
357
2618
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
16.4
8.6
13
8
D48.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Retroperitoneum
27.7
8.5
11
*
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
90.6
8.4
9
*
S18
ICPC
Laceration/cut
1.4
8.4
506
3998
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.7
8.4
165
1000
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
8.3
8
*
9695/3-C77.2
ICD-O-3
Follicular lymphoma, grade 1 of intra-abdominal lymph nodes
+∞
8.3
8
*
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
+∞
8.3
8
*
YN1AD
NOMESCO Finland
CT examination of extremities for dose design of radiotherapy
+∞
8.3
8
*
C88.0
ICD-10 Finland
Waldenström macroglobulinaemia
+∞
8.3
8
*
C83.33
ICD-10 Finland
Primary medical lymphoma with large B cells
+∞
8.3
8
*
9591/3-C77.3
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of axilla or arm
+∞
8.3
8
*
C85.0
ICD-10 Finland
Lymphosarcoma
+∞
8.3
8
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
8.3
8
*
C22.9
ICD-10 Finland
Malignant neoplasm: Liver, unspecified
+∞
8.3
8
*
9680/3-C80.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of unknown primary site
+∞
8.3
8
*
9699/3-C77.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of lymph node, NOS
+∞
8.3
8
*
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
+∞
8.3
8
*
ZXX04
NOMESCO Finland
Extent of procedure, 4 units
10.8
8.3
15
14
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
3.8
8.3
33
88
4701
FHL
Neck lymph node removal
14.6
8.2
13
9
5702
FHL
Local lymph node removal (eg armpit, groin)
33.5
8.1
10
*
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
9.0
8.0
16
18
D48.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
4.2
8.0
29
71
N02AX02
ATC
tramadol; systemic, rectal
1.4
8.0
505
4019
ELB30
NOMESCO Finland
Excision of submandibular gland
7.3
8.0
18
25
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
7.3
8.0
18
25
N05CF01
ATC
zopiclone; oral
1.4
7.9
397
3022
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
10.9
7.8
14
13
KAD00
NOMESCO Finland
Partial nephrectomy
45.2
7.7
9
*
WE100
NOMESCO Finland
Profylactic cytostatic therapy
45.2
7.7
9
*
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.1
7.7
83
404
Z3231
NOMESCO Finland
Registered nurse
1.5
7.6
304
2204
J02AC01
ATC
fluconazole; systemic
1.4
7.6
413
3187
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.0
7.6
91
464
KA3EB
NOMESCO Finland
Antegrade pyelography
25.1
7.6
10
*
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.1
7.6
39
128
XW4CT
NOMESCO Finland
Biopsy of other inner organ with CT guidance
80.5
7.4
8
*
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
80.5
7.4
8
*
A04AA03
ATC
tropisetron; systemic
80.5
7.4
8
*
J94.8
ICD-10 Finland
Other specified pleural conditions
4.6
7.4
24
53
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
13.4
7.4
12
9
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
7.3
454
3583
WX702
NOMESCO Finland
Supraglottic ventilation device
2.4
7.3
61
266
ZXA00
NOMESCO Finland
Right side
1.5
7.3
332
2471
D47.7
ICD-10 Finland
Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue
+∞
7.3
7
*
PJ2CT
NOMESCO Finland
Biopsy of lymphnode with CT guidance
+∞
7.3
7
*
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
+∞
7.3
7
*
9691/3-C77.2
ICD-O-3
Follicular lymphoma, grade 2 of intra-abdominal lymph nodes
+∞
7.3
7
*
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
7.3
7
*
L01XX47
ATC
[U] idelalisib; oral
+∞
7.3
7
*
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
+∞
7.3
7
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
7.3
7
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
7.3
7
*
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
+∞
7.3
7
*
C88.9
ICD-10 Finland
Malignant immunoproliferative disease, unspecified
+∞
7.3
7
*
C18.20
ICD-10 Finland
Malignant tumor of the ascending colon without histology
+∞
7.3
7
*
YN1BD
NOMESCO Finland
Extensive CT examination of extremities for dose design of radiotherapy
+∞
7.3
7
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
7.3
7
*
8090/3-C44.4
ICD-O-3
Basal cell carcinoma, NOS, of skin of scalp and neck
+∞
7.3
7
*
C15.5
ICD-10 Finland
Malignant neoplasm: Lower third of oesophagus
+∞
7.3
7
*
9652/3-C77.9
ICD-O-3
Hodgkin lymphoma, mixed cellularity, NOS, of lymph node, NOS
+∞
7.3
7
*
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
7.3
7
*
PJ002
NOMESCO Finland
Radical radiotherapy of neck, clavicle and axilla
+∞
7.3
7
*
C44.39
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology
+∞
7.3
7
*
C34.31
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma
+∞
7.3
7
*
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
+∞
7.3
7
*
C84.59
ICD-10 Finland
Other and unspecified T-cell lymphomas
+∞
7.3
7
*
C03CA01
ATC
furosemide; systemic
1.4
7.2
368
2800
J01CA04
ATC
amoxicillin; systemic
1.4
7.2
952
8535
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
4.8
7.2
22
46
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.0
7.1
90
469
R4190
NOMESCO Finland
Nutritional therapy
3.4
7.1
32
95
7856A
ICD-9 Finland
Symptoms involving cardiovascular system, Enlargement of lymph nodes
20.1
7.1
10
5
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.6
7.1
193
1277
ZX114
NOMESCO Finland
Intramuscular
5.1
7.1
21
42
ED1AA
NOMESCO Finland
Mandipular X-ray examination
8.0
7.1
15
19
B99
ICD-10 Finland
Other and unspecified infectious diseases
3.9
7.1
27
70
D11.70
ICD-10 Finland
Gland sublingual
8.8
7.1
14
16
KA1FN
NOMESCO Finland
Isotope renography
10.1
7.0
13
13
ZYC01
NOMESCO Finland
Remote contact by phone
2.6
7.0
49
194
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
5.2
6.9
20
39
K11.70
ICD-10 Finland
Hypoptyalism
7.6
6.9
15
20
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
13.8
6.9
11
8
GD1AD
NOMESCO Finland
Thorax CT examination
2.5
6.9
49
197
H02AB09
ATC
hydrocortisone; systemic
3.3
6.9
32
98
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
5.7
6.8
18
32
XX1AD
NOMESCO Finland
Other CT-examination
40.2
6.8
8
*
X76
ICPC
Malignant neoplasm breast female
40.2
6.8
8
*
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
40.2
6.8
8
*
A02BC05
ATC
esomeprazole; systemic
1.4
6.7
480
3870
J02AC03
ATC
voriconazole; systemic
16.8
6.7
10
6
S04
ICPC
Lump/swelling localized
1.8
6.7
104
584
Z2221
NOMESCO Finland
Medical doctor
1.4
6.7
302
2240
Z2446
NOMESCO Finland
Social worker
2.1
6.7
69
333
JMA10
NOMESCO Finland
Transabdominal total splenectomy
12.3
6.6
11
9
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.7
6.5
132
810
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.8
6.5
111
645
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
3.0
6.5
35
120
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
6.2
6.5
16
26
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
70.2
6.4
7
*
WE300
NOMESCO Finland
Profylactive therapy of malignancy with biomoidiers
70.2
6.4
7
*
L02BG03
ATC
anastrozole; oral
70.2
6.4
7
*
J94.0
ICD-10 Finland
Chylous effusion
70.2
6.4
7
*
NK1XE
NOMESCO Finland
Other ultrasound examinnation of muscle or tendon
4.7
6.4
20
43
L03AB05
ATC
interferon alfa-2b; parenteral
14.4
6.4
10
7
SPAT1088
SPAT
Blood transfusion
14.4
6.4
10
7
ZZA50
NOMESCO Finland
Full thickness skin graft
18.1
6.3
9
5
C84.0
ICD-10 Finland
Mycosis fungoides
+∞
6.3
6
*
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
+∞
6.3
6
*
C44.22
ICD-10 Finland
Spinocellular carcinoma of the skin of the outer ear and the outer ear canal
+∞
6.3
6
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
6.3
6
*
Z85.3
ICD-10 Finland
Personal history of malignant neoplasm of breast
+∞
6.3
6
*
PJD99
NOMESCO Finland
Excision of other lymph nodes
+∞
6.3
6
*
C34.11
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
+∞
6.3
6
*
EP3AT
NOMESCO Finland
Neck soft tissue biopsy with ultrasound guidance
+∞
6.3
6
*
9690/3-C77.3
ICD-O-3
Follicular lymphoma, NOS, of lymph nodes of axilla or arm
+∞
6.3
6
*
9698/3-C77.4
ICD-O-3
Follicular lymphoma, grade 3 of lymph nodes of inguinal region or leg
+∞
6.3
6
*
9691/3-C17.9
ICD-O-3
Follicular lymphoma, grade 2 of small intestine, NOS
+∞
6.3
6
*
C80.90
ICD-10 Finland
Malignant tumor without specified localization without histology
+∞
6.3
6
*
JN5JR
NOMESCO Finland
Extensive PET-CT of upper body metabolism (eyebrows to thighs)
+∞
6.3
6
*
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
6.3
6
*
C92.9
ICD-10 Finland
Myeloid leukaemia, unspecified
+∞
6.3
6
*
9691/3-C09.9
ICD-O-3
Follicular lymphoma, grade 2 of tonsil, NOS
+∞
6.3
6
*
8090/3-C44.1
ICD-O-3
Basal cell carcinoma, NOS, of eyelid
+∞
6.3
6
*
WB133
NOMESCO Finland
Very demanding adjuvant cytostatic therapy
+∞
6.3
6
*
189
Kela drug reimbursment
Imatinib
+∞
6.3
6
*
390
Kela drug reimbursment
Ibrutinib
+∞
6.3
6
*
C50.29
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology
+∞
6.3
6
*
C83.6
ICD-10 Finland
Undifferentiated (diffuse) non-Hodgkin's lymphoma
+∞
6.3
6
*
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
26.8
6.2
8
*
KH1FT
NOMESCO Finland
Exchange of urinary catheter with radiological guidance
26.8
6.2
8
*
N05BA06
ATC
lorazepam; systemic, sublingual
2.1
6.1
65
318

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
183
44
47.28
309.20
2.6
2.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
666
1021
11.00
307.65
1.4
1.5
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
1007
1218
23.48
307.65
7.4
3.3
u/l
236.1
235.3
0.06
982
1141
(40768795) Lymph node Pathology biopsy report
429
27
222.85
307.65
1.5
1.0
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
222
19
137.16
307.65
1.3
1.1
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
220
63
40.81
307.65
2.9
2.0
e9/l
1.1
1.1
0.13
159
34
(3042111) Morphology [Interpretation] in Bone marrow Narrative
270
167
19.53
307.65
1.6
1.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
321
89
45.71
307.65
1.6
1.1
—
—
—
0
0
(4035726)
550
365
23.32
307.65
1.8
1.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
708
1212
10.24
307.65
1.5
1.6
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
589
563
16.66
307.65
1.3
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
653
937
11.64
307.65
1.4
1.5
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
181
49
41.92
296.77
2.6
2.1
%
17.2
13.3
1.11
80
21
(3005719) IgG [Mass/volume] in Serum or Plasma
460
798
7.90
271.15
4.0
2.3
g/l
8.2
10.9
29.96
442
723
(3001604) Monocytes [#/volume] in Blood
1221
5768
7.22
226.24
9.6
5.5
e9/l
0.6
0.6
4.41
1123
4922
(3006315) Basophils [#/volume] in Blood
1223
5798
7.23
225.29
9.7
5.5
e9/l
0.0
0.0
3.30
1126
4961
(3010503) CD19 cells [#/volume] in Blood
139
39
39.21
224.88
2.9
2.1
e9/l
0.1
0.1
0.59
139
39
(3022096) Basophils/100 leukocytes in Blood
1154
5232
6.37
223.08
9.7
5.8
%
0.8
0.7
4.55
1128
4828
(3006504) Eosinophils/100 leukocytes in Blood
1166
5375
6.40
219.64
9.8
5.8
%
3.0
3.0
0.10
1140
4949
(3019069) Monocytes/100 leukocytes in Blood
1168
5392
6.42
219.64
10.2
6.1
%
9.7
8.8
16.25
1141
4987
(3019198) Lymphocytes [#/volume] in Blood
1225
5913
7.06
217.86
9.8
5.5
e9/l
1.7
1.9
3.70
1136
5141
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1208
5772
6.81
217.05
13.3
3.9
umol/l
10.3
12.0
8.75
1187
5381
(21494815) CD4 cells/100 lymphocytes in Specimen
146
55
29.32
215.82
2.6
2.2
%
24.9
53.3
—
16
6
(42870588) Differential panel, method unspecified - Blood
970
3903
5.27
214.42
8.7
5.6
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
1228
5998
6.99
213.55
10.4
5.6
e9/l
0.2
0.2
6.53
1136
5207
(3002030) Lymphocytes/100 leukocytes in Blood
1169
5510
6.23
210.98
10.0
5.9
%
27.1
27.5
0.49
1141
5069
(3013650) Neutrophils [#/volume] in Blood by Automated count
1261
6395
7.37
207.05
22.3
6.4
e9/l
3.4
4.3
50.63
1189
5479
(40765096) Chromosome analysis panel by Banding
117
23
55.13
205.43
1.2
1.0
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
872
3310
4.95
205.30
4.9
2.5
umol/l
1114.8
6478.3
6.27
845
2808
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
135
48
30.83
203.29
3.0
1.7
e6/l
598.0
444.9
1.45
118
43
(3018010) Neutrophils/100 leukocytes in Blood
1149
5462
5.84
201.44
9.4
5.7
%
56.5
57.6
2.36
1121
5053
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
133
48
30.33
199.25
3.1
1.7
e9/l
0.3
0.2
0.68
118
43
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
188
164
12.98
186.02
4.2
5.8
iu/ml
307.1
416.4
0.22
32
24
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
126
53
25.88
178.62
3.6
2.4
%
33.0
43.2
2.30
57
22
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
162
124
14.54
173.22
1.9
2.6
u/ml
6224.0
422.2
—
9
13
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
120
54
24.08
165.61
3.1
1.7
e6/l
425.1
844.7
2.45
50
24
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
90
15
63.80
162.54
2.5
3.1
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
97
25
41.44
159.81
2.6
2.3
%
4.5
7.6
1.31
97
25
(21494814) CD8 cells/100 lymphocytes in Specimen
97
25
41.44
159.81
2.5
2.3
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
1029
5031
4.39
158.56
7.0
3.7
g/l
35.8
35.6
0.60
986
4620
(3028026) IgM [Mass/volume] in Serum or Plasma
312
645
5.86
148.48
2.4
1.4
g/l
0.9
1.2
2.83
294
581
(3017181) Myelocytes/100 leukocytes in Blood
359
915
4.85
133.21
5.9
3.9
%
0.7
0.7
0.13
181
196
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
162
187
9.60
131.04
1.3
1.3
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
148
166
9.79
122.19
1.3
1.3
u/ml
115.8
105.6
0.36
58
29
(3021440) Promyelocytes/100 leukocytes in Blood
336
876
4.66
120.33
6.0
4.0
%
0.2
0.1
2.01
169
177
(3012095) Magnesium [Moles/volume] in Serum or Plasma
496
1743
3.77
117.34
5.6
2.6
mmol/l
0.8
0.8
2.50
478
1591
(3002179) Metamyelocytes/100 leukocytes in Blood
322
846
4.58
113.76
5.5
3.8
%
0.6
0.5
0.27
131
150
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
142
168
9.24
112.39
1.3
1.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
574
2400
3.27
100.64
8.9
4.2
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
305
847
4.27
99.34
6.0
4.0
%
0.0
0.6
0.51
139
163
(3000060) B lymphocytes [#/volume] in Blood
58
13
46.38
98.27
2.2
1.8
e6/l
78.0
263.3
—
20
6
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
152
228
7.31
98.25
2.1
1.5
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
117
132
9.53
95.82
4.1
2.8
%
2.3
1.3
1.14
95
97
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
146
217
7.35
95.10
2.1
1.5
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
412
1449
3.55
94.95
3.3
2.2
%
1.7
1.8
0.82
384
1271
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1310
9142
4.62
91.21
18.0
5.5
u/l
80.6
76.1
3.91
1294
8410
(3023520) Reticulocytes [#/volume] in Blood
343
1097
3.76
90.98
3.5
2.3
e9/l
69.5
68.4
0.26
295
846
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1012
6056
3.10
90.47
8.9
5.5
mmol/l
1.2
1.2
2.71
831
5106
(3015377) Calcium [Moles/volume] in Serum or Plasma
750
3840
2.92
89.21
7.4
2.1
mmol/l
2.4
2.4
1.49
696
3155
(40758558) Short blood count panel - Blood
593
2694
3.00
87.67
14.8
4.7
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
647
3140
2.88
83.84
7.0
4.0
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
119
163
7.85
83.14
2.2
1.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
151
278
5.93
79.57
1.3
1.5
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
720
3782
2.75
78.85
2.6
1.7
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
925
5522
2.78
78.38
7.7
5.1
mmol/l
1.2
1.2
4.20
884
4880
(3021589) Normoblasts [#/volume] in Blood
881
5143
2.75
77.84
15.6
8.6
e9/l
0.0
0.0
0.07
762
4179
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
503
2226
2.90
76.15
5.0
2.2
mmol/l
2.5
2.4
0.80
485
1899
(3002256) Pathology report gross observation
279
883
3.66
74.09
1.4
1.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
853
5100
2.58
68.57
5.6
3.6
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
50
24
21.52
66.59
3.7
1.4
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
1254
9167
3.34
66.37
7.0
4.2
mm/h
13.1
12.4
0.91
1213
8423
(3018418) pH of Serum or Plasma
662
3556
2.55
66.21
6.7
3.2
ph
7.4
7.4
0.85
187
605
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
222
660
3.78
64.21
2.9
1.4
ug/l
25.6
3.4
1.27
174
493
(3048929) Epstein Barr virus Ab [Presence] in Serum
121
234
5.54
60.21
1.2
1.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
423
1920
2.68
58.75
2.6
1.8
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
102
173
6.26
58.18
1.8
1.4
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
48
29
17.07
57.54
4.0
2.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
67
73
9.56
56.04
1.6
1.7
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
253
903
3.17
54.44
1.6
1.5
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
89
141
6.65
54.23
2.0
1.5
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
601
3319
2.36
53.82
3.7
2.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
227
789
3.21
50.89
2.0
1.5
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
84
136
6.49
50.09
1.9
1.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
75
109
7.19
49.48
2.0
1.7
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
97
183
5.60
49.46
1.2
1.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
143
373
4.14
49.32
1.9
2.9
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
87
150
6.10
48.73
1.9
1.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
91
165
5.81
48.39
1.2
1.2
u/ml
254.8
289.1
0.51
59
95
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
81
134
6.34
47.27
1.9
1.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
418
2077
2.41
46.44
2.1
1.3
g/l
1.7
2.7
25.76
324
1170
(3032080) INR in Blood by Coagulation assay
785
5056
2.17
46.20
8.8
10.1
inr
1.2
1.3
5.12
239
1441
(3020630) Protein [Mass/volume] in Serum or Plasma
259
1029
2.84
45.53
3.0
1.6
g/l
63.6
67.0
9.41
246
932
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
38
23
16.93
45.40
1.3
1.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
65
89
7.59
45.18
2.4
1.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
309
1359
2.61
44.41
2.3
1.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
306
1352
2.59
43.49
2.4
1.8
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
67
101
6.90
42.71
2.4
1.3
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
505
2809
2.21
42.30
4.9
3.5
%
92.2
87.0
4.93
498
2736
(3003458) Phosphate [Moles/volume] in Serum or Plasma
334
1559
2.47
42.13
6.1
5.0
mmol/l
1.0
1.0
0.59
320
1431
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
59
81
7.54
40.89
2.3
1.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
59
81
7.54
40.89
2.3
1.1
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
59
81
7.54
40.89
2.3
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
60
84
7.40
40.88
2.2
2.3
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
992
7203
2.13
40.24
6.0
4.3
mmol/l
6.5
6.8
6.12
956
6717
(3042936) Bacteria identified in Isolate by Culture
339
1631
2.40
39.75
1.9
2.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
86
181
4.98
38.72
1.4
1.2
miu/ml
97.5
204.7
0.96
13
74
(3008757) Leukocyte morphology finding [Identifier] in Blood
60
93
6.68
37.24
4.8
2.9
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
56
81
7.14
37.05
1.2
1.2
—
—
—
0
0
(44790049)
64
109
6.09
36.24
1.5
1.6
—
—
—
0
0
(44806118)
64
109
6.09
36.24
1.5
1.6
—
—
—
0
0
(44790047)
64
109
6.09
36.24
1.5
1.6
—
—
—
0
0
(44790048)
64
109
6.09
36.24
1.5
1.6
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
228
951
2.65
35.97
8.1
2.9
mmol/l
1.2
1.2
0.93
219
799
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
88
205
4.50
35.02
4.6
3.2
%
57.2
58.2
0.26
88
205
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
454
2576
2.10
34.93
3.4
2.1
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
260
1174
2.47
34.68
5.0
2.3
umol/l
7.2
8.3
0.29
242
1023
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
91
220
4.34
34.54
1.4
1.5
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
58
94
6.38
34.49
4.9
2.7
%
59.4
54.5
0.62
37
60
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
39
40
9.99
33.97
2.6
1.1
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
39
40
9.99
33.97
2.6
1.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
39
40
9.99
33.97
2.6
1.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
39
40
9.99
33.97
2.6
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
48
65
7.60
33.64
1.1
1.2
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
140
463
3.23
33.63
2.3
1.7
ug/l
0.6
1.7
2.36
127
406
(3002582) Erythrocytes [#/volume] in Urine
573
3575
1.98
33.59
3.6
3.0
e6/l
25.2
89.2
2.08
461
2723
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
54
88
6.33
31.93
1.3
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
33
29
11.61
31.88
2.8
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
76
174
4.55
30.89
1.1
1.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
32
29
11.26
30.29
2.8
1.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
32
29
11.26
30.29
2.8
1.1
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
518
3287
1.88
27.63
3.5
3.0
e6/l
0.3
0.4
0.41
410
2464
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
49
84
6.00
27.55
2.4
1.5
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
33
36
9.35
27.45
1.2
1.4
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
622
4204
1.82
26.93
4.4
3.5
e6/l
157.2
114.8
0.24
481
2945
(3042631) Mycobacterium sp identified in Specimen
67
156
4.45
26.66
1.9
3.1
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
419
2514
1.93
26.30
2.6
2.4
e6/l
5.2
5.5
0.15
371
2174
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
86
245
3.66
26.01
2.5
1.9
u/ml
122.9
127.1
0.01
71
191
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
39
58
6.88
25.13
2.4
1.5
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
496
3185
1.84
24.95
3.4
2.9
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
331
1866
2.00
24.74
2.9
2.0
s
29.1
29.9
2.53
325
1804
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
29
31
9.52
24.46
1.6
2.6
u/ml
1241.9
6647.8
—
7
5
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
41
67
6.26
24.17
2.3
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
449
2845
1.83
23.29
1.5
1.3
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
37
58
6.52
22.70
2.5
1.5
—
—
—
0
0
(3000012) Reticulocyte production index
39
65
6.13
22.55
1.8
1.5
—
—
—
0
0
(3026782) Osmolality of Urine
381
2323
1.86
22.21
3.1
2.6
mosm/kgh2o
514.7
544.2
1.95
343
1936
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
92
312
3.08
21.09
1.6
1.8
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
19
13
14.79
21.08
2.1
1.0
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
41
78
5.38
20.68
1.4
1.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
152
677
2.39
20.43
1.9
1.5
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
520
3545
1.72
20.41
6.3
2.7
u/l
30.0
39.7
1.26
500
3346
(3031040) Bacteria [#/volume] in Urine by Automated count
981
7922
1.70
20.03
5.4
4.4
e6/l
6.0
2628.0
2.83
19
112
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1345
11992
2.27
19.62
32.1
13.0
mg/l
22.3
23.8
0.90
1232
9291
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
537
3743
1.68
19.13
3.0
2.3
u/l
56.8
58.0
0.25
502
3399
(3026008) Bacteria identified in Urine by Culture
529
3679
1.68
18.97
3.5
3.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
60
172
3.59
18.00
1.1
1.0
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
164
797
2.19
17.89
3.2
3.2
e9/l
4.0
4.2
0.28
124
577
(3028433) Virus identified in Specimen by Culture
27
40
6.86
17.44
1.4
1.1
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
22
7
31.87
17.05
1.4
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
71
235
3.12
16.98
1.2
1.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
31
58
5.44
15.93
2.3
1.7
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
219
1239
1.90
15.63
4.9
3.2
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
1129
9724
1.67
15.48
35.1
15.9
%
14.0
13.7
13.41
1117
9459
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
174
919
2.01
15.17
1.8
2.0
g/l
0.2
0.2
0.45
162
827
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
85
332
2.65
15.04
1.5
1.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
551
4051
1.57
14.87
3.1
3.0
ng/l
1511.3
1396.0
0.28
485
3454
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
16
15
10.77
14.66
1.8
1.1
u/ml
27.3
18.4
0.47
16
15
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
658
5047
1.54
14.64
2.2
2.3
nmol/l
78.6
79.1
0.18
599
4400
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
19
23
8.35
14.52
1.0
1.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
992
8375
1.55
13.84
4.9
4.3
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
120
570
2.20
13.80
1.5
1.6
g/l
1.8
1.5
1.85
90
495
(3012441) Differential panel - Pleural fluid
38
96
4.04
13.66
1.4
1.5
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
26
48
5.50
13.56
1.4
1.1
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
290
1860
1.69
13.43
3.6
2.8
e6/l
2.2
2.5
0.19
158
987
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
45
131
3.51
13.24
1.2
1.1
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
250
1547
1.74
13.17
2.0
2.6
%
23.5
23.1
0.17
224
1305
(3000494) Fungus identified in Specimen by Culture
234
1421
1.77
13.16
1.7
1.5
—
—
—
0
0
(40768793) Breast Pathology biopsy report
35
88
4.05
12.67
1.4
1.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
362
2490
1.60
12.63
2.0
1.8
mg/l
1.3
1.3
0.01
296
1911
(3019225) pH of Specimen
210
1250
1.79
12.62
4.9
3.6
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
46
141
3.33
12.51
2.7
1.8
u/ml
501.0
45.5
0.45
41
127
(3012501) Base excess in Blood by calculation
66
251
2.71
12.34
2.8
4.5
mmol/l
3.8
2.7
2.12
53
170
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
18
25
7.28
12.28
1.0
1.1
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
15
17
8.90
12.01
1.6
1.0
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
110
535
2.14
11.93
1.4
1.4
g/l
7.6
7.4
0.41
79
395
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
110
535
2.14
11.93
1.4
1.4
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
110
535
2.14
11.93
1.4
1.4
g/l
3.4
3.9
3.62
79
383
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
636
4992
1.48
11.87
4.0
3.8
ng/l
30.5
61.0
1.67
509
3649
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
89
398
2.31
11.83
1.5
1.4
g/l
0.0
0.0
0.22
82
368
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
12
10
12.09
11.75
1.1
1.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
64
249
2.64
11.46
3.1
3.6
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
26
56
4.71
11.44
1.2
1.2
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
257
1669
1.65
11.19
2.0
2.5
g/l
2.2
2.3
1.24
242
1545
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
94
441
2.21
11.16
2.3
1.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
98
472
2.15
10.90
3.0
1.7
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
41
128
3.27
10.86
2.4
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
99
480
2.14
10.83
1.2
1.2
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
44
144
3.12
10.80
5.3
7.2
mg/l
11.5
12.3
0.57
38
133
(3009871) Measles virus Ab [Titer] in Serum
18
29
6.27
10.74
1.9
1.4
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
274
1826
1.61
10.73
2.1
2.5
umol/l
13.2
13.2
0.03
257
1677
(3025941) Bacteria identified in Stool by Culture
113
579
2.03
10.68
1.5
1.2
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
102
504
2.10
10.63
1.4
1.4
g/l
8.5
10.5
5.02
93
426
(3000991) Gas panel - Venous blood
166
969
1.80
10.59
7.8
7.5
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
93
446
2.16
10.47
1.5
1.4
g/l
0.5
0.4
0.21
83
386
(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
10
0
+∞
10.43
1.0
0.0
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
295
2016
1.58
10.36
3.3
2.6
e6/l
0.9
1.3
0.92
163
1142
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
40
127
3.21
10.33
2.4
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
80
363
2.27
10.31
2.6
3.4
u/ml
0.3
0.4
0.46
46
212
(3024522) Salmonella sp identified in Specimen by Organism specific culture
41
133
3.14
10.22
2.4
1.2
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
225
1447
1.65
10.12
7.9
6.0
mmol/l
104.1
104.3
0.25
217
1408
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
41
134
3.12
10.10
2.4
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
40
129
3.16
10.07
2.4
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
135
751
1.88
10.05
2.2
1.6
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
86
407
2.18
10.01
2.9
1.9
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
254
1691
1.61
9.93
1.3
1.2
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
187
1152
1.71
9.88
4.3
3.2
mmol/l
2.2
2.1
0.24
155
930
(3014111) Lactate [Moles/volume] in Serum or Plasma
169
1013
1.75
9.84
6.0
6.2
mmol/l
1.2
1.4
2.06
164
982
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
14
7
20.17
9.81
1.4
1.1
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
80
371
2.22
9.79
1.4
1.4
g/l
0.0
0.0
0.00
74
345
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
98
493
2.06
9.75
1.4
1.4
g/l
3.3
3.1
0.91
81
390
(3021447) Carbon dioxide [Partial pressure] in Venous blood
187
1158
1.70
9.69
4.4
3.2
kpa
5.9
5.8
0.09
179
1116
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
80
375
2.20
9.55
1.4
1.4
g/l
0.0
0.0
0.00
74
346
(3028308) Erythrocytes [#/volume] in Pleural fluid
34
103
3.35
9.47
1.3
1.5
e6/l
40954.0
92897.9
0.33
18
59
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
12
14
8.63
9.35
1.3
1.2
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
59
246
2.46
9.21
2.7
2.4
%
15.4
16.3
1.02
34
128
(3023199) Leukocytes [#/volume] in Pleural fluid
36
116
3.16
9.10
1.4
1.5
e6/l
1975.1
1786.7
0.13
25
81
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
39
133
2.98
8.96
2.5
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
54
220
2.51
8.86
3.0
2.5
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
168
1039
1.70
8.73
6.7
6.8
mmol/l
9.3
10.4
1.34
163
985
(40768800) Prostate Pathology biopsy report
28
79
3.59
8.69
1.3
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
155
940
1.72
8.65
4.0
3.9
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
24
62
3.92
8.43
1.2
1.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
24
62
3.92
8.43
1.2
1.5
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
47
185
2.59
8.29
1.6
1.9
mmol/l
1.7
1.7
0.05
47
180
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
13
9
14.55
8.20
3.9
1.3
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
14
23
6.14
8.19
1.2
1.6
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
84
427
2.03
8.16
1.5
1.4
g/l
36.8
37.8
0.69
76
361
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
26
73
3.61
8.14
1.3
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
33
109
3.07
8.03
1.2
1.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
32
104
3.12
8.00
2.8
2.1
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
93
496
1.93
7.89
1.8
1.9
u/l
41.3
38.6
0.54
85
431
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
56
246
2.33
7.84
2.2
1.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1247
11516
1.51
7.81
28.4
12.1
ml/min/173m2
76.2
76.3
0.05
1136
9232
(21494434) Karyotype in Bone marrow
32
106
3.06
7.76
1.1
1.2
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
103
572
1.86
7.73
5.1
3.7
mmol/l
25.1
24.4
1.34
88
503
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
13
21
6.24
7.72
1.3
1.3
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
60
276
2.22
7.55
2.6
2.0
g/l
122.2
132.6
2.15
45
205
(3029937) Albumin [Presence] in Urine by Test strip
414
3212
1.40
7.40
4.7
4.0
estimate
0.0
0.0
0.39
162
991
(3001122) Ferritin [Mass/volume] in Serum or Plasma
579
4766
1.35
7.10
2.9
2.7
ug/l
299.2
134.9
3.48
542
4336
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
341
2576
1.42
7.06
3.9
3.9
ng/l
362.2
475.2
0.25
288
2125
(3035350) Ketones [Presence] in Urine by Test strip
695
5887
1.34
7.01
4.4
3.7
estimate
0.0
0.0
0.00
166
1010
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
396
3075
1.39
6.98
2.1
2.2
mg/l
3.2
3.0
1.65
352
2595
(3014148) Varicella zoster virus Ab [Titer] in Serum
29
98
3.00
6.83
1.1
1.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
42
173
2.47
6.80
1.2
1.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
838
7316
1.33
6.78
3.5
3.0
u/l
52.6
47.9
0.86
778
6641
(3048879) Bone marrow aspiration report
14
28
5.04
6.71
1.9
1.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
729
6249
1.33
6.64
2.9
2.4
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
694
5911
1.33
6.60
5.8
5.0
estimate
0.0
0.0
0.00
170
1018
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
19
50
3.84
6.54
2.3
2.7
u/ml
1981.3
1096.6
0.84
19
50
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
19
50
3.84
6.54
2.8
1.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
178
1205
1.54
6.38
1.4
1.3
—
—
—
0
0
(3035880) pH of Pleural fluid
19
51
3.76
6.37
1.5
1.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
698
5975
1.32
6.30
4.5
3.7
estimate
0.0
0.0
1.08
167
987
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
155
1022
1.58
6.24
2.6
2.1
u/l
30.3
38.4
0.98
131
845
(3019832) Treponema pallidum Ab [Presence] in Serum
83
463
1.84
6.19
1.4
1.5
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
1352
12833
1.59
6.14
30.1
15.7
mmol/l
139.8
139.8
0.17
1340
12450
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
12
23
5.25
6.01
1.2
1.1
ug/l
10.3
1.4
—
7
7
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
9
6
15.07
5.90
1.1
3.3
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
72
394
1.87
5.72
2.2
1.5
mg/l
31.0
48.4
0.51
54
320
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
119
752
1.63
5.72
3.9
3.3
mmol/l
2.4
1.8
1.12
95
552
(3009343) pH of Capillary blood
123
785
1.62
5.68
4.0
3.4
ph
7.4
7.4
0.93
27
95
(3034860) Kappa light chains.free [Mass/volume] in Serum
72
395
1.86
5.68
2.2
1.5
mg/l
27.6
43.3
4.59
55
322
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
30
115
2.64
5.66
1.1
1.1
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
1351
12873
1.54
5.43
30.4
15.8
mmol/l
4.0
4.0
0.46
1336
12467
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1105
11817
0.75
5.41
5.8
6.4
mmol/mol
40.4
40.5
0.10
993
10844
(3013512) EKG study
472
3891
1.31
5.38
4.4
4.1
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
66
359
1.88
5.36
1.6
1.6
iu/ml
0.7
0.1
0.46
16
74
(3007853) Bacteria identified in Skin by Aerobe culture
187
1327
1.47
5.34
1.6
1.8
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
147
993
1.53
5.33
3.0
2.3
ml/min/173m2
62.5
63.7
0.14
58
400
(3045788) Cell count panel - Pleural fluid
26
97
2.71
5.18
1.3
1.6
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
26
99
2.66
5.00
1.8
1.4
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
95
588
1.66
4.98
3.1
2.2
%
0.6
0.6
0.10
90
558
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
49
248
2.01
4.92
1.7
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
49
248
2.01
4.92
1.7
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
16
46
3.51
4.90
1.9
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
16
46
3.51
4.90
1.9
1.2
—
—
—
0
0
(3044889) 12 lead EKG panel
972
8852
1.28
4.87
4.7
4.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
51
263
1.97
4.87
1.2
1.3
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
188
1361
1.44
4.84
6.9
6.7
mmol/l
1.9
1.2
1.93
147
1047
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1195
12594
0.74
4.83
4.8
5.5
mmol/l
2.7
2.7
0.07
1057
11471
(4062490)
28
113
2.51
4.81
1.7
1.4
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
23
84
2.77
4.79
1.9
2.0
u/l
3222.5
1413.1
0.29
11
31
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
26
103
2.55
4.64
1.2
1.2
u/l
48.5
55.5
0.48
19
73
(3036481) Cortisol [Moles/volume] in Serum or Plasma
152
1069
1.47
4.56
2.4
1.8
nmol/l
373.8
361.6
0.34
143
955
(3027801) Oxygen [Partial pressure] in Arterial blood
187
1369
1.42
4.53
7.0
6.7
kpa
12.4
11.7
0.92
179
1313
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
187
1369
1.42
4.53
7.0
6.7
kpa
5.1
5.1
0.31
178
1315
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
14
39
3.61
4.49
2.2
2.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
37
175
2.14
4.46
1.1
1.2
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
138
958
1.49
4.42
3.3
2.6
kpa
4.6
4.5
0.15
132
919
(3027135) IgG subclass 1 [Mass/volume] in Serum
27
112
2.44
4.40
1.7
1.4
g/l
4.7
7.0
2.54
22
81
(3028192) IgG subclass 2 [Mass/volume] in Serum
27
112
2.44
4.40
1.7
1.4
g/l
2.1
2.9
1.24
22
81
(3024139) IgG subclass 3 [Mass/volume] in Serum
27
112
2.44
4.40
1.7
1.4
g/l
0.3
0.4
1.52
21
80
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1351
12965
1.46
4.25
21.1
9.4
u/l
25.3
25.7
0.42
1331
12354
(3041096) Erythrocytes [Presence] in Urine by Automated
368
3017
1.29
4.22
3.9
3.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
232
1783
1.36
4.20
22.0
27.7
inr
1.3
1.4
0.20
38
250
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
41
207
2.01
4.19
2.7
2.9
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1159
12219
0.77
4.18
4.3
4.8
mmol/l
1.4
1.5
1.50
1020
11118
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
525
4510
1.25
4.08
4.7
3.9
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1171
12315
0.77
4.00
4.3
4.8
mmol/l
4.6
4.6
0.30
1039
11289
(3036048) Francisella tularensis Ab [Titer] in Serum
11
28
3.95
3.98
1.1
1.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
24
100
2.42
3.90
1.1
1.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
194
1467
1.37
3.89
1.3
1.4
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
8
11
7.31
3.86
1.6
1.7
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
9
15
6.03
3.81
1.3
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
77
487
1.61
3.77
1.5
1.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
59
349
1.72
3.72
2.1
3.5
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1120
11811
0.79
3.62
3.9
4.3
mmol/l
1.3
1.3
1.31
979
10641
(40760888) Immunoglobulin light chains.free panel - Serum
51
293
1.77
3.57
2.4
1.4
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
32
157
2.06
3.57
1.5
1.4
pmol/l
95.4
63.4
1.68
32
151
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
16
57
2.83
3.53
1.9
1.2
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
90
601
1.53
3.51
8.5
8.8
mmol/l
25.1
24.4
1.59
83
551
(3023323) Follitropin [Units/volume] in Serum or Plasma
38
200
1.92
3.50
1.3
1.2
iu/l
28.1
29.0
0.04
27
176
(3023419) Bacteria identified in Sputum by Culture
36
186
1.96
3.50
2.3
2.8
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
165
1237
1.38
3.50
7.7
6.9
%
95.8
95.1
1.08
158
1197
(3024980) IgG subclass 4 [Mass/volume] in Serum
34
173
1.99
3.45
1.8
1.8
g/l
0.4
1.0
2.08
27
136
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
16
58
2.78
3.42
1.1
1.1
u/l
30.4
18.8
0.49
11
39
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
16
58
2.78
3.42
1.9
1.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
25
113
2.23
3.42
1.5
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
57
343
1.69
3.41
1.5
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
57
344
1.68
3.37
1.5
1.1
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
9
18
5.02
3.37
1.8
1.2
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
7
10
7.03
3.36
1.1
1.2
%
80.4
107.2
—
7
10
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
7
10
7.03
3.36
1.1
1.2
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
47
269
1.77
3.35
1.7
1.2
e6/l
6.3
38.9
0.86
37
218
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
47
269
1.77
3.35
1.7
1.3
e6/l
173.2
874.1
0.83
38
228
(42529406) Shigella sp [Presence] in Stool by Culture
57
347
1.67
3.28
1.5
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
18
72
2.52
3.21
2.0
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
18
72
2.52
3.21
2.0
1.2
—
—
—
0
0
(3024932) HLA-DR beta [Type]
11
33
3.35
3.19
1.6
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
11
34
3.25
3.06
1.0
1.0
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
10
29
3.46
3.05
2.5
1.3
—
—
—
0
0
(3020891) Body temperature
76
508
1.52
2.99
4.4
4.3
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
52
319
1.65
2.93
1.9
1.7
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
20
414
0.48
2.87
1.3
1.7
mg/l
5.6
4.7
0.10
15
297
(3002173) Hemoglobin [Mass/volume] in Arterial blood
148
1134
1.34
2.76
8.3
7.3
g/l
117.2
121.8
1.75
138
1096
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
26
132
1.99
2.71
1.5
1.9
—
1616.0
—
0
5
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
14
54
2.61
2.70
1.0
1.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
344
2934
1.22
2.70
4.5
3.6
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1117
10602
1.21
2.69
28.4
14.7
%
38.3
39.6
4.08
711
6931
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
87
618
1.43
2.57
9.7
9.7
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
98
712
1.40
2.56
2.0
2.2
nmol/l
12.8
14.7
1.15
89
627
(1002224) Polysomnography panel
21
408
0.51
2.54
1.0
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
83
586
1.44
2.54
4.1
3.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
394
4494
0.83
2.52
4.0
4.0
mg/mmol
7.5
8.0
0.10
236
2797
(3024891) Influenza virus A+B Ag [Presence] in Specimen
41
248
1.67
2.48
1.4
1.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
372
4258
0.83
2.46
3.2
3.3
mg/l
244.6
226.9
0.03
219
2644
(3004616) Nuclear Ab [Presence] in Serum
5
160
0.31
2.42
1.6
1.2
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
32
182
1.77
2.40
1.6
1.3
u/l
8.5
9.1
0.11
26
151
(3045424) Erythrocytes [Presence] in Urine
34
197
1.74
2.40
1.9
1.5
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
51
329
1.57
2.40
1.4
1.4
ug/g
282.7
302.4
0.39
35
193
(4281824)
15
64
2.36
2.39
1.1
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
45
696
0.64
2.37
1.4
1.4
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
5
8
6.27
2.37
1.0
1.0
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
5
8
6.27
2.37
1.0
1.0
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
987
9310
1.18
2.34
3.9
3.9
pmol/l
15.1
14.9
1.12
898
8343
(3019060) Gas panel - Arterial blood
108
812
1.36
2.31
4.9
4.6
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
42
263
1.61
2.25
1.2
1.4
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
14
60
2.35
2.22
1.0
1.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
139
1096
1.30
2.16
3.9
3.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
38
235
1.63
2.15
1.7
1.2
—
—
—
0
0
(4024509)
23
124
1.87
2.07
1.8
1.7
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
13
56
2.33
2.05
1.4
1.3
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
13
56
2.33
2.05
3.0
4.7
—
—
—
0
0
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
6
15
4.01
2.04
1.2
1.0
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
14
64
2.20
1.94
1.4
1.5
u/l
14.4
8.6
—
8
28
(3021960) Folate [Moles/volume] in Serum or Plasma
360
3180
1.17
1.89
1.6
1.5
nmol/l
20.9
21.0
0.06
317
2634
(3023410) Appearance of Cerebral spinal fluid
21
116
1.82
1.79
2.4
1.3
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
101
787
1.30
1.75
7.0
6.5
mmol/l
25.5
24.4
1.66
91
732
(3047189) Immunofixation for 24 hour Urine
8
30
2.68
1.72
1.1
1.0
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
36
234
1.55
1.71
1.7
1.7
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
147
1205
1.24
1.70
2.5
3.1
ng/l
267.7
200.9
0.91
134
1108
(3024928) Oxygen saturation in Venous blood
40
268
1.51
1.67
3.3
2.7
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
6
19
3.17
1.66
1.7
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
6
19
3.17
1.66
1.2
1.6
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
54
385
1.42
1.65
6.3
5.8
mmol/l
1.1
1.3
1.32
47
344
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
17
91
1.88
1.60
1.1
1.2
mmol/l
2.0
2.0
0.08
17
86
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
20
113
1.78
1.60
1.2
1.3
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
48
337
1.44
1.60
1.2
1.4
—
18.3
—
0
10
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
81
621
1.32
1.60
2.4
3.1
pmol/l
4.4
4.5
0.69
74
536
(3045414) Leukocytes [Presence] in Urine
74
560
1.34
1.60
2.3
1.8
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
395
4366
0.87
1.59
3.1
3.2
mmol/l
7.0
7.3
0.90
310
3658
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
29
183
1.60
1.58
1.1
1.1
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
13
64
2.04
1.54
2.4
6.9
—
69.1
—
0
19
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
20
115
1.75
1.53
1.2
1.1
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
14
72
1.95
1.49
2.2
1.8
nmol/l
18.8
17.3
0.20
14
61
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
18
305
0.59
1.47
1.3
1.1
—
8.1
—
0
24
(3032057) Clostridioides difficile [Presence] in Stool
7
28
2.51
1.45
1.6
2.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
18
102
1.77
1.45
1.1
1.2
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
64
482
1.34
1.45
1.0
1.1
—
307.1
—
0
15
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
5
16
3.13
1.44
1.0
1.3
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
12
59
2.04
1.43
1.0
1.0
—
—
—
0
0
(40768441) Liver Pathology biopsy report
12
59
2.04
1.43
1.0
1.3
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
12
59
2.04
1.43
1.0
1.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
39
272
1.45
1.38
1.1
1.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
53
391
1.37
1.37
2.6
2.7
g/l
0.2
0.3
0.85
27
129
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
38
535
0.70
1.35
1.3
1.5
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1276
12457
1.17
1.34
24.1
12.8
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
18
105
1.72
1.33
1.3
1.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
355
3901
0.88
1.29
3.1
3.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
289
2591
1.14
1.25
1.7
1.8
nmol/l
1213.7
1162.7
0.34
209
1921
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
105
1268
0.82
1.24
1.6
1.6
—
—
—
0
0
(3019977) pH of Arterial blood
12
63
1.91
1.23
2.5
2.4
ph
7.4
7.4
—
5
24
(3013293) Extractable nuclear Ab [Presence] in Serum
5
19
2.64
1.21
1.0
1.6
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
326
3587
0.88
1.20
1.6
1.7
mmol/l
1.4
1.4
0.71
271
2970
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
36
256
1.42
1.18
1.3
1.3
—
483.3
—
0
6
(3007461) Platelets [#/volume] in Blood
1361
13383
1.20
1.17
43.6
19.3
e9/l
225.5
246.0
23.10
1343
12927
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
22
141
1.57
1.17
1.0
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
61
778
0.77
1.16
1.8
1.8
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
42
308
1.37
1.16
1.8
1.8
—
—
—
0
0
(3024731) MCV [Entitic volume]
1361
13385
1.20
1.16
43.4
19.2
fl
91.6
91.4
0.77
1356
13114
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
0
34
0.00
1.16
0.0
1.5
—
143.1
—
0
26
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
14
235
0.59
1.15
1.6
1.4
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
35
0.00
1.15
0.0
1.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
198
1739
1.16
1.15
11.5
6.6
—
—
—
0
0
(3035941) MCH [Entitic mass]
1361
13387
1.20
1.14
43.3
19.2
pg
30.4
30.4
0.01
1356
13116
(3026361) Erythrocytes [#/volume] in Blood
1361
13388
1.19
1.14
43.6
19.3
e12/l
4.3
4.5
23.05
1340
12871
(3001019) Free T4 and TSH panel - Serum or Plasma
27
389
0.69
1.13
1.4
1.8
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
1361
13390
1.19
1.12
43.6
19.3
e9/l
6.3
6.7
12.62
1339
12874
(3000963) Hemoglobin [Mass/volume] in Blood
1361
13390
1.19
1.12
43.8
19.4
g/l
130.5
136.0
31.57
1356
13115
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
7
30
2.34
1.12
1.0
1.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
8
40
2.01
1.12
1.1
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
31
217
1.44
1.12
1.8
1.5
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
7
33
2.13
1.05
1.1
1.1
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
12
67
1.80
1.04
2.6
3.0
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
24
162
1.49
1.04
1.4
1.5
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
12
203
0.59
1.03
1.1
1.1
—
101.2
—
0
35
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
7
34
2.06
1.03
1.1
1.1
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
19
122
1.56
1.02
2.4
3.1
mg/l
20.9
17.8
0.14
12
96
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
118
1008
1.19
0.98
3.1
3.7
ng/l
74.4
89.3
1.07
93
871
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
11
61
1.81
0.98
1.2
2.3
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
5
23
2.18
0.98
1.2
1.1
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
0
30
0.00
0.97
0.0
1.3
—
0.7
—
0
17
(3051101) Glucose [Moles/volume] in Cord blood
0
30
0.00
0.97
0.0
5.8
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
9
50
1.80
0.96
2.9
1.7
ug/l
16.2
12.6
—
9
42
(3000330) Specific gravity of Urine by Test strip
82
678
1.22
0.96
4.2
3.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
174
1962
0.87
0.95
1.2
1.2
u/ml
16.4
13.2
0.16
56
731
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
9
51
1.77
0.94
1.0
1.2
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
37
1.90
0.94
1.0
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
165
1455
1.15
0.93
1.3
1.4
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
64
518
1.25
0.92
5.7
4.5
%
1.6
1.6
0.17
57
489
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
55
1.82
0.92
1.0
1.1
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
13
78
1.67
0.91
1.4
1.2
u/l
37.9
32.3
0.24
13
57
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
6
28
2.15
0.91
1.2
1.1
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
6
28
2.15
0.91
1.7
1.9
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
23
159
1.45
0.91
2.9
2.2
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
6
29
2.07
0.89
1.5
2.8
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
147
1291
1.15
0.89
2.0
2.2
ug/g
134.2
149.6
0.29
120
1009
(3019150) Specific gravity of Urine by Refractometry
292
2684
1.11
0.86
5.1
4.1
kg/l
1.0
1.0
0.09
44
402
(3005322) IgE [Units/volume] in Serum or Plasma
79
661
1.21
0.85
1.3
1.2
u/ml
133.5
243.2
1.11
60
607
(3000475) Leukocytes [#/volume] in Synovial fluid
24
332
0.72
0.85
2.2
1.6
e6/l
6712.7
13412.3
1.24
18
243
(3003181) Sodium [Moles/volume] in Urine
29
213
1.37
0.84
1.4
1.4
mmol/l
66.5
65.9
0.02
24
169
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
6
31
1.94
0.84
1.0
2.4
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
6
32
1.88
0.82
1.2
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
20
138
1.46
0.81
1.2
1.3
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
13
81
1.61
0.81
1.4
1.7
—
73.9
—
0
7
(3051651) Icteric interference index of Serum or Plasma
10
58
1.73
0.79
1.7
4.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
343
3679
0.91
0.79
4.1
3.7
%
20.9
24.0
3.47
160
1747
(3044941) Cell count panel - Synovial fluid
15
223
0.67
0.79
2.1
1.5
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
8
48
1.67
0.78
1.0
1.0
—
—
—
0
0
(3016750) Collection duration of Urine
13
82
1.59
0.78
1.8
2.1
min
514.5
496.0
—
6
64
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
43
340
1.27
0.78
1.3
1.6
g/l
0.3
0.2
1.45
43
325
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
28
0.00
0.76
0.0
1.0
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
76
895
0.84
0.76
1.2
1.2
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
5
24
2.09
0.74
1.2
1.8
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
5
25
2.00
0.72
1.0
1.5
g/l
14.1
10.7
—
5
17
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
5
25
2.00
0.72
2.4
3.7
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
14
92
1.53
0.72
1.0
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
21
151
1.40
0.71
1.3
1.3
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
10
61
1.64
0.68
1.1
1.2
u/l
82.1
83.2
—
10
51
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
5
27
1.85
0.68
1.2
2.1
mmol/l
1.2
1.2
—
5
27
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
7
42
1.67
0.68
1.1
1.1
miu/ml
1271.1
1604.1
—
7
42
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
5
92
0.54
0.67
1.2
1.4
—
56.7
—
0
6
(3010375) cycloSPORINE [Mass/volume] in Blood
7
43
1.63
0.67
34.9
26.3
ug/l
78.1
131.6
—
7
34
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
5
95
0.52
0.66
1.2
1.4
—
181.5
—
0
13
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
20
145
1.38
0.66
4.0
4.1
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
12
78
1.54
0.65
3.6
1.7
—
12.7
—
0
5
(40757373) Influenza virus identified in Isolate
5
29
1.73
0.64
1.4
1.7
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
103
1164
0.88
0.63
1.5
1.7
%
1.4
1.5
1.63
84
976
(3044927) Protein electrophoresis panel - Urine
11
165
0.66
0.63
1.0
1.1
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
8
49
1.64
0.62
1.0
1.2
iu/ml
188.0
230.1
—
8
49
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
8
49
1.64
0.62
1.1
1.3
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
5
30
1.67
0.61
1.4
1.6
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
8
50
1.60
0.61
1.3
1.2
—
16.3
—
0
8
(3007930) Methemoglobin/Hemoglobin.total in Blood
60
509
1.19
0.60
6.1
4.5
%
1.0
0.9
0.49
54
482
(4198724)
0
20
0.00
0.60
0.0
1.0
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
0
20
0.00
0.60
0.0
1.3
—
5.7
—
0
10
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
158
1733
0.90
0.60
4.3
5.0
%
30.9
32.8
1.42
99
1130
(3037522) Nuclear Ab [Titer] in Serum
174
1594
1.10
0.58
1.3
1.3
titre
492.4
593.3
0.24
29
374
(1761482) Bacteria [#/volume] in Urine by Culture
40
328
1.23
0.57
4.9
4.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
88
0.57
0.56
1.4
1.2
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
45
375
1.21
0.56
4.2
4.1
mmol/l
3.9
3.9
0.11
39
353
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
6
37
1.62
0.55
1.0
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
21
159
1.33
0.55
1.1
1.3
nmol/l
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
15
107
1.41
0.55
1.3
2.7
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
9
60
1.50
0.54
1.0
1.3
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
9
60
1.50
0.54
1.0
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
46
544
0.84
0.53
1.7
1.7
—
—
—
0
0
(3011648) Oxygen content in Venous blood
14
100
1.40
0.52
1.8
1.9
%
11.0
10.7
0.06
14
100
(4268621)
14
100
1.40
0.52
1.8
2.3
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
12
83
1.45
0.52
2.8
2.6
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
19
248
0.76
0.51
2.0
1.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
30
369
0.81
0.51
1.3
1.4
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
6
41
1.47
0.50
1.3
1.6
—
—
—
0
0
(3039000) Anion gap in Blood
33
270
1.23
0.50
8.8
6.4
mmol/l
10.8
11.2
0.33
28
245
(3018572) Chloride [Moles/volume] in Blood
33
270
1.23
0.50
8.8
6.5
mmol/l
106.6
105.5
0.86
28
245
(3014051) Protein [Presence] in Urine by Test strip
37
307
1.21
0.49
2.6
2.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
7
45
1.56
0.49
1.1
1.2
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
16
119
1.35
0.48
1.8
1.4
%
27.0
28.1
—
8
75
(3023511) Choriogonadotropin [Units/volume] in Urine
7
47
1.49
0.47
1.0
1.2
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
7
48
1.46
0.46
1.0
1.9
ug/l
13.8
185.4
—
7
42
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
134
1231
1.10
0.45
2.1
2.4
ug/l
5.3
7.7
0.50
117
1083
(3025130) Human papilloma virus identified in Specimen
12
86
1.40
0.44
1.9
1.8
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
7
51
1.37
0.44
1.0
1.0
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
41
479
0.85
0.43
1.6
1.6
—
—
—
0
0
(4010399)
86
953
0.90
0.43
1.4
1.4
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
16
206
0.77
0.41
1.3
1.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1215
12288
0.94
0.41
4.8
5.0
mmol/l
5.9
6.0
2.27
1081
11059
(3016330) Potassium [Moles/time] in 24 hour Urine
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
5
34
1.47
0.40
1.0
1.1
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
18
0.00
0.40
0.0
1.2
—
1.9
—
0
18
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.7
—
16.0
—
0
18
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
7
102
0.68
0.39
1.0
1.6
—
24.6
—
0
21
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
13
171
0.76
0.39
1.5
1.7
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
13
97
1.34
0.39
3.5
3.1
%
13.5
13.2
0.48
13
97
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
2.8
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
5
36
1.39
0.38
3.0
1.9
ug/l
0.3
1.7
—
5
30
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
5
36
1.39
0.38
1.0
1.2
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
22
179
1.23
0.37
1.1
1.3
nmol/l
—
0.5
—
0
14
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
192
2036
0.93
0.37
1.2
1.3
iu/ml
25.7
39.3
1.02
54
636
(3013166) Neutrophils/100 leukocytes in Synovial fluid
5
37
1.35
0.37
1.8
1.4
%
57.4
63.6
—
5
32
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1142
11280
1.05
0.36
4.7
4.8
mu/l
2.0
2.1
0.27
1045
10139
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
31
263
1.18
0.36
1.6
2.0
iu/l
9.5
4.4
—
8
93
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
303
2910
1.05
0.32
1.7
1.7
pmol/l
469.9
26728931.4
2.37
243
2372
(4094501)
32
370
0.86
0.32
1.0
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
37
423
0.87
0.32
1.6
1.6
—
—
—
0
0
(3000492) Spirometry study
110
1022
1.08
0.32
1.4
1.5
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
32
276
1.16
0.32
4.0
3.5
mg/l
35.0
25.9
0.57
23
172
(3004775) Volume in Urine collected for unspecified duration
15
119
1.26
0.31
2.5
2.4
ml
733.0
612.1
—
6
83
(3007566) Smooth muscle Ab [Titer] in Serum
35
305
1.15
0.31
1.3
1.1
—
88.3
—
0
24
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
12
93
1.29
0.30
1.1
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
12
93
1.29
0.30
1.1
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
12
93
1.29
0.30
1.1
1.2
—
—
—
0
0
(4306422)
12
151
0.79
0.28
1.2
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
12
151
0.79
0.28
1.1
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
13
103
1.26
0.28
1.0
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
56
616
0.91
0.28
1.3
1.3
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
8
63
1.27
0.27
1.0
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
12
95
1.27
0.26
1.1
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
12
95
1.27
0.26
1.1
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
12
95
1.27
0.26
1.1
1.2
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
5
71
0.70
0.26
1.0
1.0
—
0.4
—
0
18
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
5
72
0.69
0.26
1.0
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
64
696
0.92
0.26
1.2
1.2
iu/ml
34.7
135.5
4.70
17
271
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
14
114
1.23
0.25
1.9
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
5
39
1.28
0.23
1.0
1.0
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
7
91
0.77
0.22
1.3
1.6
umol/l
14.9
13.3
—
7
83
(40768446) Kidney Pathology biopsy report
5
41
1.22
0.22
1.6
1.6
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
235
2432
0.96
0.22
1.2
1.2
u/ml
0.7
1.9
3.02
44
628
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3025315) Body weight
0
10
0.00
0.21
0.0
3.5
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
5
43
1.16
0.21
2.0
1.5
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
13
0.00
0.21
0.0
6.5
—
5.9
—
0
13
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.2
—
180.1
—
0
7
(44806071)
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
13
0.00
0.21
0.0
2.3
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
19
164
1.16
0.20
1.2
1.3
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
14
0.00
0.20
0.0
2.2
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
6
49
1.23
0.20
1.0
1.2
—
0.1
—
0
5
(4034850)
41
447
0.91
0.19
10.3
10.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
87
824
1.06
0.18
1.1
1.3
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
10
121
0.83
0.18
1.1
1.3
—
32.6
—
0
5
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
7
62
1.13
0.17
1.3
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
13
110
1.18
0.17
1.5
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
67
709
0.94
0.16
2.7
2.4
—
—
—
0
0
(4146454)
19
168
1.13
0.15
3.4
2.8
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
6
78
0.77
0.15
1.3
1.3
u/l
4.9
6.1
—
6
67
(3034770) Mitochondria Ab [Titer] in Serum
34
313
1.09
0.15
1.3
1.2
—
1688.2
—
0
11
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
50
533
0.94
0.15
1.0
1.0
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
13
112
1.16
0.14
1.5
1.1
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
10
85
1.18
0.12
1.2
1.2
mmol/l
36.0
33.9
—
10
73
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
18
162
1.11
0.12
1.0
1.0
—
—
—
0
0
(3003338) MCHC [Mass/volume]
986
9920
0.98
0.11
38.5
17.4
g/l
331.8
332.3
1.20
980
9842
(1001926) Buprenorphine [Presence] in Urine by Screen method
14
124
1.13
0.11
1.1
1.7
—
—
—
0
0
(3008898) HLA-B27 [Presence]
33
309
1.07
0.10
1.1
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
87
841
1.04
0.10
2.8
3.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
253
2572
0.98
0.09
2.9
2.7
ug/l
0.7
0.7
0.71
171
1727
(3025018) Bordetella pertussis Ab [Titer] in Serum
6
55
1.09
0.09
1.0
1.3
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
16
175
0.91
0.08
1.6
1.5
%
65.4
63.7
—
8
113
(44813793)
5
62
0.81
0.08
1.0
1.0
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
6
71
0.84
0.07
1.8
1.5
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
6
75
0.80
0.07
29.0
11.5
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
8
74
1.08
0.07
1.1
2.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
8
74
1.08
0.07
2.3
1.9
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
7
81
0.86
0.07
1.3
1.4
g/l
0.8
1.0
—
7
81
(3010726) Horse dander IgE Ab [Units/volume] in Serum
7
84
0.83
0.07
1.0
1.0
u/ml
—
2.5
—
0
20
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
459
4554
1.01
0.06
4.5
3.9
ug/l
2.3
2.0
0.66
396
4083
(3027944) Amphetamines [Presence] in Urine
17
158
1.08
0.06
1.1
1.5
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
35
364
0.96
0.05
2.5
2.3
ug/min
85.0
83.1
0.02
13
225
(3016879) Cocaine [Presence] in Urine
14
151
0.93
0.05
1.1
1.8
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
21
222
0.95
0.05
1.6
1.7
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
10
110
0.91
0.05
2.1
2.0
ug/l
2.3
3.3
—
10
100
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
12
110
1.09
0.05
1.1
1.1
%
87.5
92.5
0.22
12
104
(3027008) Opiates [Presence] in Urine
17
160
1.06
0.04
1.1
1.8
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
17
160
1.06
0.04
1.1
1.8
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
554
5564
0.99
0.03
2.0
2.0
pmol/l
94.4
94.8
0.06
284
2741
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
16
151
1.06
0.03
1.0
1.0
g/l
1.7
1.5
0.77
16
127
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
31
301
1.03
0.02
1.4
1.4
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
414
4155
0.99
0.02
2.2
2.2
u/l
228.8
236.9
0.03
394
3881
(3025577) Chromium [Mass/volume] in Blood
10
107
0.93
0.02
2.3
2.1
ug/l
2.1
2.0
—
10
93
(3000764) Benzodiazepines [Presence] in Urine
16
158
1.01
0.00
1.1
1.8
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
20
203
0.99
0.00
1.5
1.8
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
15
155
0.97
0.00
1.3
1.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
12
115
1.04
0.00
1.8
3.6
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3004451) EKG impression Narrative
6
63
0.95
0.00
1.2
1.3
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
5
57
0.88
0.00
2.0
2.2
—
—
—
0
0
(3040893) Potassium [Moles/volume] in Capillary blood
0
5
0.00
0.00
0.0
2.4
—
4.4
—
0
5
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
6.0
—
0
6
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
6
62
0.97
0.00
1.2
1.2
nmol/l
121.8
142.6
—
6
62
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
39
390
1.00
0.00
1.5
1.9
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
7
75
0.93
0.00
1.6
1.7
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
9
91
0.99
0.00
2.0
1.6
—
1.5
—
0
7
(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
10.3
—
0
5
(3045683) HLA typing for celiac disease panel - Blood or Tissue
5
57
0.88
0.00
1.0
1.0
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
9
96
0.94
0.00
1.7
1.1
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.6
—
453.0
—
0
7
(3017509) Phencyclidine [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
8
79
1.01
0.00
2.3
1.8
—
—
—
0
0
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
259.5
—
0
6
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013762) Body weight Measured
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: CD2_FOLLICULAR_LYMPHOMA_EXALLC – Follicular lymphoma

GWS hits: 4

This endpoint is excluded (different definition than used in FinnGen).